IbogaBase
Schedule I in the U.S.Serious cardiac riskNot FDA-approvedNo dosing or referrals

Claim extract · Listening Library

Washington Post (2024): healing hail vs U.S. illegality

LAST REVIEWED 2026-09-22 · MEDIA CLAIM EXTRACT · HIGH-CONFIDENCE LL

High-confidence Listening Library journalism row (Washington Post, 14 Mar 2024). Patient/veteran narrative and access questions — not a controlled efficacy trial and not a change in federal scheduling or FDA approval.

Listening Library source (outbound)

washington-post-audio-adjacent-2024 — Washington Post article. Confidence: high. Primary page confirmed via WebFetch (2026-09-22 PT); some automated clients receive blocks.

Testable claims (media → desk)

  1. Claim: Public “hailed as healing” framing implies settled proof for PTSD/TBI/addiction.
    Desk: PTSD · TBI · OUD — observational limits remain; journalism ≠ endpoints.
  2. Claim: U.S. patients ask why access is illegal — implies Schedule I is merely outdated paperwork.
    Desk: Schedule I vs state bills FAQ — state funding/politics ≠ federal descheduling.
  3. Claim: Access conversation implies FDA-approved pathway already exists.
    Desk: FDA approval FAQ · noribogaine permission ≠ approval.
  4. Safety omission risk: Healing headlines can bury cardiac risk.
    Desk: Safety · QTc · natural ≠ safe.

Verdict

Strong policy/access journalism extract; does not prove efficacy, does not repeal Schedule I, and does not equal FDA approval.

Continue reading

Policy hub · Perry / Hubbard policy media · Listening Library